Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 37 of 95, showing 5 Applications out of 474 total, starting on record 181, ending on 185

# Protocol No Study Title Investigator(s) & Site(s)

181.

ECCT/18/07/03   Development of innovative integrated system to reduce malaria transmission towards elimination in the Lake Victoria basin, Kenya
    Development of innovative integrated system to reduce malaria transmission towards elimination   in the Lake Victoria basin, Kenya   
Principal Investigator(s)
1. WATARU KAGAYA
2. KINYA UCHIHASHI
Site(s) in Kenya
HOMA BAY DISTRICT HOSPITAL
 
View

182.

ECCT/18/07/04   Expedited Partner Therapy and Partner Self-testing
    Evaluation of Expedited partner therapy/Partner HIV self-testing for young women enrolled in POWER study and diagnosed with sexually transmitted infections in Kisumu   
Principal Investigator(s)
1. Prof. Elizabeth Bukusi Anne Bukusi
Site(s) in Kenya
Kisumu
 
View

183.

ECCT/18/07/06   Hestia 3
    A Randomised, Double-Blind, Parallel-Group, Multicentre, Phase III Study to Evaluate the Effect of Ticagrelor versus Placebo in Reducing the Rate of Vaso-Occlusive Crises in Paediatric Patients with Sickle Cell Disease   
Principal Investigator(s)
1. Prof Jessie Nyokabi Githanga
2. Videlis Nduba
3. Janet N Oyieko
4. Bernards Ragama Ogutu
Site(s) in Kenya
1. Gertrude’s Children’s Hospital (Nairobi City county)
2. Chandaria Health Center Clinical Research Clinic (Nairobi City county)
3. Kenya Medical Research Institute (KEMRI) Kisumu (Kisumu county)
4. KEMRI Kombewa Clinical Research Centre (Nairobi City county)
5. Kondele Children\'s Hospital (Kisumu county)
6. Strathmore University Medical Centre (Nairobi City county)
 
View

184.

ECCT/18/07/07   A Randomized, Open, Parallel-group, Single Dose, Phase 2a Study, to Investigate the Clinical and Parasiticidal Activity and the Pharmacokinetics of 3 dose levels of Artefenomel in combination with Ferroquine (FQ) and FQ alone, in African Patients with Unc
    A Randomized, Open label, Parallel-group, Single Dose Regimen, Phase 2a Study, to Investigate the Clinical and Parasiticidal Activity and the Pharmacokinetics of 3 dose levels of Artefenomel (OZ439) given in combination with Ferroquine (FQ) and FQ alone, in African Patients with Uncomplicated Plasmodium falciparum Malaria   
Principal Investigator(s)
1. GRACE KIRINGA KAGUTHI
Site(s) in Kenya
1. Center for Respiratory Diseases Research (Siaya county)
2. KEMRI (Kisumu county)
 
View

185.

ECCT/18/08/01   NOVICE-M Trial
    NOn-invasive Ventilation In Children with CErebral Malaria Trial   
Principal Investigator(s)
1. Professor Kathryn Maitland
Site(s) in Kenya
Kilifi County Hospital
 
View